Explore the full record of transactions filed by PELLETIER SAUNDRA L, Chairman & CEO. Insider active across 3 companies, notably Evofem Biosciences, Inc.. Aggregated, 12 disclosures have been published. Total volume traded: €263k. The latest transaction was filed on 27 May 2022 — Acquisition. Regulator: SEC (Form 4). The full history is free.
Saundra L. Pelletier is the Chairman & CEO of Evofem Biosciences, Inc. and Tracon Pharmaceuticals, Inc. She also serves as a Director at these companies. Her responsibilities include strategic and operational leadership, aiming to maximize shareholder value and ensure sustainable growth.